drugset / Trial / NCT00086411

Comparing Smoking Treatment Programs for Lighter Smokers - 1

NCT00086411

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.

Timeline

Start
2003-09
Primary completion
2008-04
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other

Indications